MedPath

Color Fundus Photograph With Experts Labelling

Recruiting
Conditions
Diabetic Retinopathy
Retinal Disease
Registration Number
NCT06287645
Lead Sponsor
Pakistan Council of Scientific and Industrial Research
Brief Summary

This trial aims to provide a digital retinal image dataset from Pakistan, graded by three specialists according to the severity of Diabetic Retinopathy. The dataset aims to improve research and patient care.

Detailed Description

This clinical trial aims to address the scarcity of retinal image datasets in Pakistan by providing a comprehensive digital fundus photograph dataset, accompanied by expert grading. The dataset will encompass retinal images from Pakistani individuals, meticulously labeled by three Vitreo Retinal Specialists. These specialists will assess the presence and severity of common retinal disorders, including No Diabetic Retinopathy (No DR), Mild, Moderate, Severe, Proliferative Diabetic Retinopathy, Clinically Significant Macular Edema (CSME), and Advance diabetic Eye Diseases (ADED). Each image will also be evaluated for diagnostic clarity and the presence of any additional findings. Final grading decisions will be reached through unanimous consensus among the graders, ensuring the dataset's reliability and accuracy. This initiative holds promise for advancing ophthalmic research and improving patient care in Pakistan and beyond.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50000
Inclusion Criteria
  • Patients with Type I or Type II Diabetes.
  • Patients of age of 20 years or above
Exclusion Criteria
  • The participant is unable or unwilling to comply with study procedures.
  • Vulnerable participants (minors, legally detained individuals).
  • Prisoners or subjects who are involuntarily incarcerated.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Grading Diabetic Retinopathy Severity according to Early Treatment of Diabetic Retinopathy Scale1 Visit (1 day)

Each Fundus photograph will be evaluated according to the Severity of Diabetic Retinopathy following Early Treatment of Diabetic Retinopathy Scale (ETDRS). Following Diabetic Retinopathy symptoms will be graded according to this scale.

1. Clinically Significant Macular Edema

2. Advance Diabetic Eye Disease

Grading Diabetic Retinopathy Severity according to International Clinical Diabetic Retinopathy Severity Scale1 Visit (1 day)

Each Fundus photograph will be evaluated according to the Severity of Diabetic Retinopathy following International Clinical Diabetic Retinopathy Severity Scale (ICDRSS). Following Diabetic Retinopathy symptoms will be graded according to this scale.

1. No DR

2. Mild

3. Moderate

4. Severe

5. Proliferative

Finding inter-rater agreement among the gradersTwo Years

The intraclass correlation coefficient will be calculated using the collected dataset to assess the consistency in grading among all graders.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Al Ibrahim Eye Hospital

🇵🇰

Karachi, Pakistan

© Copyright 2025. All Rights Reserved by MedPath